C139H138F3N21O9S — CID 159551286
1-[3-(2,1,3-benzothiadiazol-5-yl)-1H-isoindol-5-yl]-2-[(3S)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]ethanone;2-(1-benzyl-5,5-difluoropiperidin-3-yl)-1-(3-pyridin-4-yl-1H-isoindol-5-yl)ethanone;methyl (2R,5S)-1-benzyl-5-[2-oxo-2-(3-pyridin-4-yl-1H-indazol-5-yl)ethyl]piperidine-2-carboxylate;N-[1-[2-(4-methylphenyl)ethyl]azepan-3-yl]-3-pyridin-4-yl-1H-indazole-5-carboxamide;N-(1-phenacylazepan-3-yl)-3-pyridin-4-yl-1H-indazole-5-carboxamide (PubChem CID 159551286) has the molecular formula C139H138F3N21O9S and a molecular weight of 2335.83 g/mol. Its IUPAC name is 1-[3-(2,1,3-benzothiadiazol-5-yl)-1H-isoindol-5-yl]-2-[(3S)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]ethanone;2-(1-benzyl-5,5-difluoropiperidin-3-yl)-1-(3-pyridin-4-yl-1H-isoindol-5-yl)ethanone;methyl (2R,5S)-1-benzyl-5-[2-oxo-2-(3-pyridin-4-yl-1H-indazol-5-yl)ethyl]piperidine-2-carboxylate;N-[1-[2-(4-methylphenyl)ethyl]azepan-3-yl]-3-pyridin-4-yl-1H-indazole-5-carboxamide;N-(1-phenacylazepan-3-yl)-3-pyridin-4-yl-1H-indazole-5-carboxamide.
| Compound Name | 1-[3-(2,1,3-benzothiadiazol-5-yl)-1H-isoindol-5-yl]-2-[(3S)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]ethanone;2-(1-benzyl-5,5-difluoropiperidin-3-yl)-1-(3-pyridin-4-yl-1H-isoindol-5-yl)ethanone;methyl (2R,5S)-1-benzyl-5-[2-oxo-2-(3-pyridin-4-yl-1H-indazol-5-yl)ethyl]piperidine-2-carboxylate;N-[1-[2-(4-methylphenyl)ethyl]azepan-3-yl]-3-pyridin-4-yl-1H-indazole-5-carboxamide;N-(1-phenacylazepan-3-yl)-3-pyridin-4-yl-1H-indazole-5-carboxamide |
|---|---|
| PubChem CID | 159551286 |
| Molecular Formula | C139H138F3N21O9S |
| Molecular Weight | 2335.83 g/mol |
| Exact Mass | 2334.07 |
| IUPAC Name | 1-[3-(2,1,3-benzothiadiazol-5-yl)-1H-isoindol-5-yl]-2-[(3S)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]ethanone;2-(1-benzyl-5,5-difluoropiperidin-3-yl)-1-(3-pyridin-4-yl-1H-isoindol-5-yl)ethanone;methyl (2R,5S)-1-benzyl-5-[2-oxo-2-(3-pyridin-4-yl-1H-indazol-5-yl)ethyl]piperidine-2-carboxylate;N-[1-[2-(4-methylphenyl)ethyl]azepan-3-yl]-3-pyridin-4-yl-1H-indazole-5-carboxamide;N-(1-phenacylazepan-3-yl)-3-pyridin-4-yl-1H-indazole-5-carboxamide |
| SMILES | COC(=O)[C@H]1CC[C@@H](CC(=O)c2ccc3[nH]nc(-c4ccncc4)c3c2)CN1Cc1ccccc1.COc1cccc(F)c1CN1CCC[C@@H](CC(=O)c2ccc3c(c2)C(c2ccc4nsnc4c2)=NC3)C1.Cc1ccc(CCN2CCCCC(NC(=O)c3ccc4[nH]nc(-c5ccncc5)c4c3)C2)cc1.O=C(CC1CN(Cc2ccccc2)CC(F)(F)C1)c1ccc2c(c1)C(c1ccncc1)=NC2.O=C(CN1CCCCC(NC(=O)c2ccc3[nH]nc(-c4ccncc4)c3c2)C1)c1ccccc1 |
| InChI | InChI=1S/C29H27FN4O2S.C28H31N5O.C28H28N4O3.C27H25F2N3O.C27H27N5O2/c1-36-28-6-2-5-24(30)23(28)17-34-11-3-4-18(16-34)12-27(35)19-7-8-21-15-31-29(22(21)13-19)20-9-10-25-26(14-20)33-37-32-25;1-20-5-7-21(8-6-20)13-17-33-16-3-2-4-24(19-33)30-28(34)23-9-10-26-25(18-23)27(32-31-26)22-11-14-29-15-12-22;1-35-28(34)25-10-7-20(18-32(25)17-19-5-3-2-4-6-19)15-26(33)22-8-9-24-23(16-22)27(31-30-24)21-11-13-29-14-12-21;28-27(29)14-20(17-32(18-27)16-19-4-2-1-3-5-19)12-25(33)22-6-7-23-15-31-26(24(23)13-22)21-8-10-30-11-9-21;33-25(19-6-2-1-3-7-19)18-32-15-5-4-8-22(17-32)29-27(34)21-9-10-24-23(16-21)26(31-30-24)20-11-13-28-14-12-20/h2,5-10,13-14,18H,3-4,11-12,15-17H2,1H3;5-12,14-15,18,24H,2-4,13,16-17,19H2,1H3,(H,30,34)(H,31,32);2-6,8-9,11-14,16,20,25H,7,10,15,17-18H2,1H3,(H,30,31);1-11,13,20H,12,14-18H2;1-3,6-7,9-14,16,22H,4-5,8,15,17-18H2,(H,29,34)(H,30,31)/t18-;;20-,25+;;/m0.0../s1 |
| InChIKey | MFKPNRSDFKNTBT-ZDCNOVGBSA-N |
| XLogP | 24.34 |
| TPSA | 366.31 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 173 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2335.83 |
| LogP ≤ 5 | 24.34 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 26 |